Logo image of B7E.DE

BLUE CAP AG (B7E.DE) Stock Fundamental Analysis

Europe - Frankfurt Stock Exchange - FRA:B7E - DE000A0JM2M1 - Common Stock

18.2 EUR
+1 (+5.81%)
Last: 1/12/2026, 7:00:00 PM
Fundamental Rating

5

B7E gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 125 industry peers in the Capital Markets industry. While B7E belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. B7E has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year B7E was profitable.
B7E had a positive operating cash flow in the past year.
Of the past 5 years B7E 4 years were profitable.
In the past 5 years B7E always reported a positive cash flow from operatings.
B7E.DE Yearly Net Income VS EBIT VS OCF VS FCFB7E.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M

1.2 Ratios

B7E has a Return On Assets of 9.48%. This is amongst the best in the industry. B7E outperforms 87.20% of its industry peers.
The Return On Equity of B7E (20.25%) is better than 81.60% of its industry peers.
Looking at the Return On Invested Capital, with a value of 6.33%, B7E is in the better half of the industry, outperforming 74.40% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for B7E is below the industry average of 8.63%.
The 3 year average ROIC (5.02%) for B7E is below the current ROIC(6.33%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 9.48%
ROE 20.25%
ROIC 6.33%
ROA(3y)0.97%
ROA(5y)2.64%
ROE(3y)1.48%
ROE(5y)6.13%
ROIC(3y)5.02%
ROIC(5y)5.41%
B7E.DE Yearly ROA, ROE, ROICB7E.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

1.3 Margins

Looking at the Profit Margin, with a value of 11.71%, B7E is in line with its industry, outperforming 48.00% of the companies in the same industry.
In the last couple of years the Profit Margin of B7E has grown nicely.
B7E has a Operating Margin (8.02%) which is comparable to the rest of the industry.
In the last couple of years the Operating Margin of B7E has grown nicely.
B7E's Gross Margin of 49.70% is fine compared to the rest of the industry. B7E outperforms 63.20% of its industry peers.
B7E's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 8.02%
PM (TTM) 11.71%
GM 49.7%
OM growth 3Y20.55%
OM growth 5Y16.85%
PM growth 3Y49.43%
PM growth 5Y38.76%
GM growth 3Y2.24%
GM growth 5Y2.56%
B7E.DE Yearly Profit, Operating, Gross MarginsB7E.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40 50

5

2. Health

2.1 Basic Checks

B7E has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, B7E has more shares outstanding
Compared to 1 year ago, B7E has an improved debt to assets ratio.
B7E.DE Yearly Shares OutstandingB7E.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M
B7E.DE Yearly Total Debt VS Total AssetsB7E.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

An Altman-Z score of 2.20 indicates that B7E is not a great score, but indicates only limited risk for bankruptcy at the moment.
B7E's Altman-Z score of 2.20 is fine compared to the rest of the industry. B7E outperforms 71.20% of its industry peers.
The Debt to FCF ratio of B7E is 4.61, which is a neutral value as it means it would take B7E, 4.61 years of fcf income to pay off all of its debts.
B7E's Debt to FCF ratio of 4.61 is fine compared to the rest of the industry. B7E outperforms 72.80% of its industry peers.
A Debt/Equity ratio of 0.32 indicates that B7E is not too dependend on debt financing.
B7E's Debt to Equity ratio of 0.32 is fine compared to the rest of the industry. B7E outperforms 68.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF 4.61
Altman-Z 2.2
ROIC/WACCN/A
WACCN/A
B7E.DE Yearly LT Debt VS Equity VS FCFB7E.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M 100M

2.3 Liquidity

B7E has a Current Ratio of 1.73. This is a normal value and indicates that B7E is financially healthy and should not expect problems in meeting its short term obligations.
B7E's Current ratio of 1.73 is fine compared to the rest of the industry. B7E outperforms 76.80% of its industry peers.
B7E has a Quick Ratio of 1.39. This is a normal value and indicates that B7E is financially healthy and should not expect problems in meeting its short term obligations.
B7E has a Quick ratio of 1.39. This is in the better half of the industry: B7E outperforms 75.20% of its industry peers.
Industry RankSector Rank
Current Ratio 1.73
Quick Ratio 1.39
B7E.DE Yearly Current Assets VS Current LiabilitesB7E.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 292.72% over the past year.
Measured over the past years, B7E shows a very strong growth in Earnings Per Share. The EPS has been growing by 33.00% on average per year.
B7E shows a decrease in Revenue. In the last year, the revenue decreased by -0.59%.
The Revenue has been decreasing by -1.79% on average over the past years.
EPS 1Y (TTM)292.72%
EPS 3Y33.45%
EPS 5Y33%
EPS Q2Q%1599.7%
Revenue 1Y (TTM)-0.59%
Revenue growth 3Y-8.3%
Revenue growth 5Y-1.79%
Sales Q2Q%-4.28%

3.2 Future

The Earnings Per Share is expected to decrease by -60.16% on average over the next years. This is quite bad
B7E is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -5.74% yearly.
EPS Next Y-37.05%
EPS Next 2Y-41.74%
EPS Next 3Y-60.16%
EPS Next 5YN/A
Revenue Next Year-38.12%
Revenue Next 2Y-19.99%
Revenue Next 3Y-12.19%
Revenue Next 5Y-5.74%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
B7E.DE Yearly Revenue VS EstimatesB7E.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 100M 200M 300M
B7E.DE Yearly EPS VS EstimatesB7E.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2020 2021 2022 2023 2024 2025 2026 2027 0 2 4 6 8 10

5

4. Valuation

4.1 Price/Earnings Ratio

B7E is valuated cheaply with a Price/Earnings ratio of 4.04.
Compared to the rest of the industry, the Price/Earnings ratio of B7E indicates a rather cheap valuation: B7E is cheaper than 97.60% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of B7E to the average of the S&P500 Index (27.30), we can say B7E is valued rather cheaply.
B7E is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE 4.04
Fwd PE N/A
B7E.DE Price Earnings VS Forward Price EarningsB7E.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -100 -200 -300 -400

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, B7E is valued cheaply inside the industry as 95.20% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of B7E indicates a rather cheap valuation: B7E is cheaper than 92.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 5.87
EV/EBITDA 3.06
B7E.DE Per share dataB7E.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

The decent profitability rating of B7E may justify a higher PE ratio.
B7E's earnings are expected to decrease with -60.16% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.12
EPS Next 2Y-41.74%
EPS Next 3Y-60.16%

4

5. Dividend

5.1 Amount

B7E has a Yearly Dividend Yield of 3.85%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 3.32, B7E pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 1.92, B7E pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.85%

5.2 History

The dividend of B7E decreases each year by -2.84%.
Dividend Growth(5Y)-2.84%
Div Incr Years0
Div Non Decr Years1
B7E.DE Yearly Dividends per shareB7E.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

The Dividend Rate of B7E has been decling, while earnings will also be declining. This means the current dividend is most likely not sustainable.
DP0%
EPS Next 2Y-41.74%
EPS Next 3Y-60.16%
B7E.DE Yearly Income VS Free CF VS DividendB7E.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M

BLUE CAP AG

FRA:B7E (1/12/2026, 7:00:00 PM)

18.2

+1 (+5.81%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)11-04 2025-11-04
Earnings (Next)03-26 2026-03-26/amc
Inst Owners25.55%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap81.72M
Revenue(TTM)174.60M
Net Income(TTM)20.44M
Analysts82.86
Price Target30.87 (69.62%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.85%
Yearly Dividend0.65
Dividend Growth(5Y)-2.84%
DP0%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-0.44%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)283.67%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.87%
Valuation
Industry RankSector Rank
PE 4.04
Fwd PE N/A
P/S 0.47
P/FCF 5.87
P/OCF 4.03
P/B 0.81
P/tB 1.55
EV/EBITDA 3.06
EPS(TTM)4.51
EY24.78%
EPS(NY)-0.04
Fwd EYN/A
FCF(TTM)3.1
FCFY17.03%
OCF(TTM)4.51
OCFY24.8%
SpS38.89
BVpS22.48
TBVpS11.77
PEG (NY)N/A
PEG (5Y)0.12
Graham Number47.76
Profitability
Industry RankSector Rank
ROA 9.48%
ROE 20.25%
ROCE 9.09%
ROIC 6.33%
ROICexc 9.23%
ROICexgc 16.8%
OM 8.02%
PM (TTM) 11.71%
GM 49.7%
FCFM 7.97%
ROA(3y)0.97%
ROA(5y)2.64%
ROE(3y)1.48%
ROE(5y)6.13%
ROIC(3y)5.02%
ROIC(5y)5.41%
ROICexc(3y)6.63%
ROICexc(5y)7.25%
ROICexgc(3y)11.85%
ROICexgc(5y)10.59%
ROCE(3y)7.26%
ROCE(5y)7.8%
ROICexgc growth 3Y54.39%
ROICexgc growth 5Y35.47%
ROICexc growth 3Y30.62%
ROICexc growth 5Y18.26%
OM growth 3Y20.55%
OM growth 5Y16.85%
PM growth 3Y49.43%
PM growth 5Y38.76%
GM growth 3Y2.24%
GM growth 5Y2.56%
F-Score8
Asset Turnover0.81
Health
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF 4.61
Debt/EBITDA 1.04
Cap/Depr 37.43%
Cap/Sales 3.64%
Interest Coverage 3.69
Cash Conversion 65.44%
Profit Quality 68.08%
Current Ratio 1.73
Quick Ratio 1.39
Altman-Z 2.2
F-Score8
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)25.83%
Cap/Depr(5y)33.96%
Cap/Sales(3y)2.24%
Cap/Sales(5y)2.56%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)292.72%
EPS 3Y33.45%
EPS 5Y33%
EPS Q2Q%1599.7%
EPS Next Y-37.05%
EPS Next 2Y-41.74%
EPS Next 3Y-60.16%
EPS Next 5YN/A
Revenue 1Y (TTM)-0.59%
Revenue growth 3Y-8.3%
Revenue growth 5Y-1.79%
Sales Q2Q%-4.28%
Revenue Next Year-38.12%
Revenue Next 2Y-19.99%
Revenue Next 3Y-12.19%
Revenue Next 5Y-5.74%
EBIT growth 1Y224.21%
EBIT growth 3Y10.55%
EBIT growth 5Y14.76%
EBIT Next Year-0.64%
EBIT Next 3Y-20.6%
EBIT Next 5Y-13.53%
FCF growth 1Y-38.99%
FCF growth 3Y7.4%
FCF growth 5YN/A
OCF growth 1Y-27.35%
OCF growth 3Y1.47%
OCF growth 5Y47.8%

BLUE CAP AG / B7E.DE FAQ

What is the ChartMill fundamental rating of BLUE CAP AG (B7E.DE) stock?

ChartMill assigns a fundamental rating of 5 / 10 to B7E.DE.


Can you provide the valuation status for BLUE CAP AG?

ChartMill assigns a valuation rating of 5 / 10 to BLUE CAP AG (B7E.DE). This can be considered as Fairly Valued.


What is the profitability of B7E stock?

BLUE CAP AG (B7E.DE) has a profitability rating of 7 / 10.


What is the earnings growth outlook for BLUE CAP AG?

The Earnings per Share (EPS) of BLUE CAP AG (B7E.DE) is expected to decline by -37.05% in the next year.


Is the dividend of BLUE CAP AG sustainable?

The dividend rating of BLUE CAP AG (B7E.DE) is 4 / 10 and the dividend payout ratio is 0%.